Mr. David Robinson reports


Blackrock Gold Corp. has appointed Dr. Alan Carter to the board of directors. Dr. Carter has 30 years of experience in the mining and minerals exploration industry. He spent seven years working for Rio Tinto Corp. in South America and the United Kingdom, and in 1996, he became president and chief executive officer of Balaclava Mines. Dr. Carter joined Billiton PLC in 1998, and in 2000, he moved from Lima, Peru, to Vancouver. Following the merger of Billiton with BHP, he assumed the role of manager, business development, within the BHP Billiton Exploration Group and was the chief operating officer of Peregrine Diamonds Ltd. from mid-2004 to late 2006. Dr. Carter was president and CEO of Magellan Minerals Ltd. until its recent sale to Anfield Gold Corp. in May, 2016. He is a director of Peregrine Diamonds Ltd. and Anfield Gold Corp. Dr. Carter has a BSc in geology from the University of Nottingham in the U.K., and a PhD in gold geochemistry and structural geology from the University of Southampton in the U.K.

“Alan has a proven track record in creating shareholder value, as was especially shown in the recent sale of Magellan Minerals to Anfield Gold, which closed in May of this year. We are very pleased to welcome him to the board of Blackrock Gold,” commented David R. Robinson, president and CEO of Blackrock.

To accommodate the appointment of Dr. Carter to the board, Randy Minhas, the chief financial officer of Blackrock, has agreed to step down as a director. Mr. Minhas will continue in his role as CFO. The company welcomes the continued involvement of Mr. Minhas with Blackrock.

Furthermore, Blackrock has granted 100,000 incentive stock options to Dr. Carter. The options, which are subject to the terms and conditions of the company’s stock option plan and the policies of the TSX Venture Exchange, may be exercised at a price of nine cents per share for a term of five years.